Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 15, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | Thunder Bridge Capital Partners III Inc. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Amendment Flag | false | |
Entity Central Index Key | 0001815753 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-39998 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 85-1445798 | |
Entity Address, Address Line One | 9912 Georgetown Pike | |
Entity Address, Address Line Two | Suite D203 | |
Entity Address, City or Town | Great Falls | |
Entity Address, State or Province | VA | |
Entity Address, Postal Zip Code | 22066 | |
City Area Code | (202) | |
Local Phone Number | 431-0507 | |
Entity Interactive Data Current | Yes | |
Units, each consisting of one share of Class A common stock and one-fifth of one redeemable Warrant | ||
Document Information Line Items | ||
Trading Symbol | TBCPU | |
Title of 12(b) Security | Units, each consisting of one share of Class A common stock and one-fifth of one redeemable Warrant | |
Security Exchange Name | NASDAQ | |
Class A common stock, par value $0.0001 per share | ||
Document Information Line Items | ||
Trading Symbol | TBCP | |
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | |
Security Exchange Name | NASDAQ | |
Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share | ||
Document Information Line Items | ||
Trading Symbol | TBCPW | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share | |
Security Exchange Name | NASDAQ | |
Class A Common Stock | ||
Document Information Line Items | ||
Entity Common Stock, Shares Outstanding | 2,100,741 | |
Class B Common Stock | ||
Document Information Line Items | ||
Entity Common Stock, Shares Outstanding | 10,350,000 |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash | $ 318,353 | $ 180,109 |
Prepaid expenses | 87,480 | 30,013 |
Total current assets | 405,833 | 210,122 |
Other assets: | ||
Cash and marketable securities held in Trust Account | 11,950,441 | 12,263,483 |
Total assets | 12,356,274 | 12,473,605 |
Current liabilities: | ||
Accounts payable and accrued expenses | 664,094 | 500,117 |
Income taxes payable | 1,126,638 | 1,111,143 |
Warrant liability | 1,020,380 | 680,940 |
Promissory note payable - related party, at fair value | 425,000 | 475,000 |
Total current liabilities | 3,236,112 | 2,767,200 |
Deferred underwriting fee payable | 14,490,000 | 14,490,000 |
Total liabilities | 17,726,112 | 17,257,200 |
Commitments | ||
Shares subject to possible redemption, 1,097,741 and 41,400,000, at March 31, 2023 and December 31, 2022, respectively, at redemption value | 11,134,946 | 11,152,340 |
Stockholders’ Equity (Deficit): | ||
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding | ||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,003,000 and 0 shares issued and outstanding (excluding 41,400,000 and 1,097,741 shares subject to possible redemption), at March 31, 2023 and December 31, 2022, respectively | 100 | 100 |
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 10,350,000 shares issued and outstanding at March 31, 2023 and December 31, 2022 | 1,035 | 1,035 |
Additional paid in capital | ||
Accumulated deficit | (16,505,919) | (15,937,070) |
Total stockholders’ equity (deficit) | (16,504,784) | (15,935,935) |
Total liabilities and stockholders’ equity (deficit) | $ 12,356,274 | $ 12,473,605 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parentheticals) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Shares subject to possible redemption value (in Dollars) | $ 1,097,741 | $ 41,400,000 |
Preferred shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred shares, shares authorized | 1,000,000 | 1,000,000 |
Preferred shares, shares outstanding | ||
Class A Common Stock | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | 1,003,000 | 0 |
Common stock, shares outstanding | 1,003,000 | 0 |
Common stock, shares subject to possible redemption | 41,400,000 | 1,097,741 |
Class B Common Stock | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 20,000,000 | 20,000,000 |
Common stock, shares issued | 10,350,000 | 10,350,000 |
Common stock, shares outstanding | 10,350,000 | 10,350,000 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Formation costs and other operating expenses | $ 229,408 | $ 290,060 |
Loss from operations | (229,408) | (290,060) |
Other income: | ||
Interest income | 73,787 | 36,909 |
Change in fair value of warrant liability | (339,440) | 2,719,059 |
Income before income taxes | (495,061) | 2,465,908 |
Income tax expense | 15,495 | |
Net income | $ (510,556) | $ 2,465,908 |
Class A Common Stock | ||
Other income: | ||
Weighted average shares outstanding (in Shares) | 2,100,741 | 42,403,000 |
Basic and diluted net income per share (in Dollars per share) | $ (0.02) | $ 0.05 |
Class B Common Stock | ||
Other income: | ||
Weighted average shares outstanding (in Shares) | 10,350,000 | 10,350,000 |
Basic and diluted net income per share (in Dollars per share) | $ (0.05) | $ 0.05 |
Condensed Statements of Opera_2
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A Common Stock | ||
Basic and diluted net income per share | $ (0.02) | $ 0.05 |
Class B Common Stock | ||
Basic and diluted net income per share | $ (0.05) | $ 0.05 |
Condensed Statements of Changes
Condensed Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($) | Class A Common Stock | Class B Common Stock | Additional Paid in Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2021 | $ 100 | $ 1,035 | $ (21,155,409) | $ (21,154,274) | |
Balance (in Shares) at Dec. 31, 2021 | 1,003,000 | 10,350,000 | |||
Common Stock subject to redemption | (36,909) | (36,909) | |||
Common Stock subject to redemption (in Shares) | |||||
Net income (loss) | 2,465,908 | 2,465,908 | |||
Balance at Mar. 31, 2022 | $ 100 | $ 1,035 | (18,726,410) | (18,725,275) | |
Balance (in Shares) at Mar. 31, 2022 | 1,003,000 | 10,350,000 | |||
Balance at Dec. 31, 2022 | $ 100 | $ 1,035 | (15,937,070) | (15,935,935) | |
Balance (in Shares) at Dec. 31, 2022 | 1,003,000 | 10,350,000 | |||
Common Stock subject to redemption | 75,687 | (58,293) | 17,394 | ||
Common Stock subject to redemption (in Shares) | |||||
Common Stock redeemed | (75,687) | (75,687) | |||
Net income (loss) | (510,556) | (510,556) | |||
Balance at Mar. 31, 2023 | $ 100 | $ 1,035 | $ (16,505,919) | $ (16,504,784) | |
Balance (in Shares) at Mar. 31, 2023 | 1,003,000 | 10,350,000 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash flow from operating activities: | ||
Net income | $ (510,556) | $ 2,465,908 |
Adjustments to reconcile net income to net cash used in operating activities: | ||
Interest earned in Trust Account | (73,787) | (36,909) |
Change in fair value of warrant liability | 339,440 | (2,719,059) |
Changes in operating assets and liabilities: | ||
Prepaid expenses | (57,467) | 48,349 |
Accounts payable and accrued expenses | 163,977 | 54,251 |
Income taxes payable | 15,495 | |
Net cash provided by (used in) operating activities | (122,898) | (187,460) |
Cash flows from investing activities: | ||
Redemption of cash in Trust Account | 1,456,251 | |
Recoveries of excess Trust Account redemptions | (1,069,422) | |
Net cash provided by investing activities | 386,829 | |
Cash flows from financing activities: | ||
Repayment of promissory note - related party | (50,000) | |
Redemption of Class A common stock | (75,687) | |
Net cash provided by financing activities | (125,687) | |
Net change in cash | 138,244 | (187,460) |
Cash at the beginning of the period | 180,109 | 336,290 |
Cash at the end of the period | $ 318,353 | $ 148,830 |
Description of Organization and
Description of Organization and Business Operations | 3 Months Ended |
Mar. 31, 2023 | |
Description of Organization and Business Operations [Abstract] | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Thunder Bridge Capital Partners III, Inc. (the “Company,” ) is a blank check company incorporated in Delaware on June 12, 2020. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2023, the Company had not yet commenced any operations. All activity for the period of June 12, 2020 (inception) through March 31, 2023 related to the Company’s formation, the initial public offering that was consummated by the Company on February 10, 2021 (the “Initial Public Offering”) and subsequent to the completion of the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with on January 15, 2021, as amended (File No. 333- 252109) was declared effective on February 4, 2021 (the “Registration Statement”). On February 10, 2021, the Company consummated the Initial Public Offering of 41,400,000 units (“Units” and, with respect to the (i) shares of Class A common stock included in the Units offered, the “Public Shares” and (ii) redeemable warrants included in the Units offered, the “Public Warrants”), generating gross proceeds of $414,000,000 (see Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,003,000 private placement units (the “Private Placement Units”) at a price of $10.00 per unit in a private placement to TBCP III, LLC (the “Sponsor”), generating gross proceeds of $10,030,000 Note 4). The Private Placement Units consist of one share of Class A common stock, $0.0001 par value (the “Private Placement Shares”), and one-fifth of one redeemable warrant (the “Private Placement Warrants” ). Each whole Private Placement Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share. Following the closing of the Initial Public Offering on February 10, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (“Trust Account”) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. February 28, 2023 Continental at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below. Transaction costs amounted to $23,191,740 consisting of $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees (see Note 6) and $421,740 of other costs. Of the transaction costs, $463,835 associated with the issuance of warrants that have been classified as a liability have been expensed during the year ended December 31, 2021. In addition, at the closing of the Initial Public Offering, $1,263,117 of cash was held outside of the Trust Account and was available for working capital purposes. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters of the Initial Public Offering (see Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These shares of Class A common stock will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5), the Private Placement Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) and Private Placement Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and Private Placement Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. At the Meeting (as defined in Note 8) held on December 16, 2022, the stockholders of the Company approved an amendment to the Amended and Restated Certificate of Incorporation to extend the date by which the Company has to either consummate a Business Combination or wind up the Company and redeem 100% of the Public Shares sold in the Initial Public Offering from February 10, 2023 to August 10, 2023 (or such earlier date as determined by the board of directors of the Company (the “Board of Directors”)) (the “Combination Period”). If the Company is unable to complete a Business Combination by the end of the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board of Directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriters of the Initial Public Offering have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. If the Company has not completed a Business Combination by the end of the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding Public Shares, which redemption will completely extinguish the rights of the Public Stockholders as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. In the event of a liquidation, the Public Stockholders will be entitled to receive a full pro rata interest in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the Trust Fund not previously released to the Company and less up to $100,000 of interest to pay dissolution expenses). There will be no redemption rights or liquidating distributions with respect to the Founder Shares Private Placement Shares or the Private Placement Warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Company has completed its Initial Public Offering, at which time, capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to the Company for general working capital purposes. Additionally, the Sponsor has executed the Promissory Note (as defined in Note 5) to loan the Company up to $1,500,000. Through March 31, 2023, the Company has borrowed $475,000 under the Promissory Note. Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements, which. do not include any adjustments that might result from the outcome of this uncertainty. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Liquidity and Going Concern Consideration As of March 31, 2023, the Company had a working capital deficit of approximately $2,830,000, including approximately $318,000 in its operating bank account. The Company’s liquidity needs to date have been satisfied through (i) a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, (ii) an advance from an affiliate of the Sponsor of the payment of certain formation and operating costs on behalf of the Company and (iii) the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, as of March 31, 2023 and December 31, 2022, there were $425,000 and $450,000 amounts outstanding under the Promissory Note (see Note 5). In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), we have evaluated the Company’s liquidity and financial condition and determined that it is probable the Company will not be able to meet its obligations over the period of one year from the issuance date of the accompanying unaudited condensed financial statements. In addition, while the Company plans to seek additional funding or to consummate an initial Business Combination, there is no guarantee the Company will be able to borrow such funds from its Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors in order to meet its obligations through the earlier of the consummation of an initial Business Combination or one year from this filing. We have determined that the uncertainty surrounding the Company’s liquidity condition raises substantial doubt about its ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022, respectively. Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. Shares Subject to Possible Redemption The Company accounts for its shares subject to possible redemption in accordance with the guidance in ASC 480. Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares are classified as stockholders’ equity. The Company’s shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, shares subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the accompanying unaudited condensed balance sheets. Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs are charged against the carrying value of Class A common stock or the statement of operations based on the relative value of the Class A common stock and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, offering costs in the aggregate of $23,191,740 were recognized, $463,835 of which was allocated to the warrants and immediately expensed included in formation costs and other operating expenses in the accompanying unaudited condensed statements of operations, and $22,727,905 was allocated to Class A common stock, reducing the carrying amount of such shares. Cash Held in Trust Account At March 31, 2023, the assets in the Trust Account were held in a demand deposit account and at December 31, 2022, the assets held in the Trust Account were invested in a money market fund. In February 2023, the assets held in the Trust Account were converted into cash. Net (Loss) Income Per Share of Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share” (“ASC 260”). We have two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding during the period. The calculation of diluted loss per share does not consider the effect of the Public Warrants issued in connection with the Initial Public Offering and the sale of the Private Placement Warrants in the Private Placement, because the exercise of the warrants is contingent upon the occurrence of future events. A reconciliation of net (loss) income per share of common stock is as follows: For the Three Months Ended March 31, 2023 For the Three Months Ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net income per share Allocation of net income, as adjusted $ (86,143 ) $ (424,413 ) $ 1,982,103 $ 483,805 Less: Accretion allocated based on ownership percentage (9,835 ) (48,458 ) (29,668 ) (7,241 ) Plus: Accretion applicable to Class A redeemable shares 58,293 36,909 Income (loss) by class $ (37,685 ) $ (472,871 ) $ 1,989,344 $ 476,564 Denominator: Basic and diluted weighted average common shares outstanding 2,100,741 10,350,000 42,403,000 10,350,000 Basic and diluted net income (loss) per share $ (0.02 ) $ (0.05 ) $ 0.05 $ 0.05 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the accompanying unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements. Subsequent Events Management of the Company evaluates events that have occurred after the balance sheet date of March 31, 2023 through the date the financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2023 | |
Initial Public Offering [Abstract] | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING On February 10, 2021, 41,400,000 Units at a purchase price of $10.00 per Unit, Each Unit consists of one Public Share and one fifth of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 7). |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2023 | |
Private Placement [Abstract] | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of 1,003,000 Private Placement Units at a price of $10.00 per unit for an aggregate purchase price of $10,030,000 in the Private Placement. Each Private Placement Unit is identical to the Units offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Shares or Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On August 26, 2020, the Company issued an aggregate of 8,625,000 shares of Class B common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In February 2021, the Company effected a stock dividend of 0.2 shares for each Founder Share outstanding, resulting in the Sponsor holding an aggregate number of 10,350,000 Founder Shares. The Founder Shares included an aggregate of up to 1,350,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would collectively own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). February 10, 2021, The Sponsor has agreed not to transfer, assign, or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities, or other property. Notwithstanding the foregoing, if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into units at a price of $10.00 per unit. The units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 25, 2022, the Company executed a promissory note, representing a Working Capital Loan from the Sponsor, for the Sponsor to loan funds to the Company up to $1,500,000 (the “Promissory Note”). At March 31, 2023 and December 31, 2022 there was $425,000 and $475,000 outstanding under the Promissory Note, respectively. The fair value of the Promissory Note as of March 31, 2023 and December 31, 2022 was $425,000 and $475,000, with changes in fair value recorded to the accompanying unaudited condensed statements of operations. For the three months ended March 31, 2023, there were no changes in fair value recorded to the accompanying unaudited condensed statements of operations. Administrative Support Agreement The Company entered into an agreement, whereby, commencing on February 10, 2021, through the earlier of the consummation of a Business Combination or the Company’s liquidation, the Company pays an affiliate of the Sponsor a total of $10,000 per month for office space, utilities, and secretarial and administrative support. The Company had incurred $30,000 for the three months ended March 31, 2023 and 2022, respectively. Advisory Agreement The Company entered into an agreement, whereby, commencing on February 10, 2021, through the earlier of the consummation of a Business Combination or the Company’s liquidation, the Company pays an affiliate of its Chief Executive Officer a monthly fee of $20,000 for advisory services related to its search for and consummation of its Business Combination. The Company had incurred $60,000 for the three months ended March 31, 2023 and 2022, respectively. Initial Public Offering In February 2021, our Chief Executive Officer purchased 100,000 Units at a price of $10.00 per Unit for an aggregate purchase price of $1,000,000 as part of our Initial Public Offering. |
Commitments
Commitments | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS | NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on February 10, 2021, the holders of the Founder Shares, Private Placement Units (and their underlying securities) and the units that may be issued upon conversion of the Working Capital Loans (and their underlying securities) are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters of the Initial Public Offering a 45-day option to purchase up to 5,400,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions, which was exercised on February 10, 2021. The underwriters were paid a cash underwriting discount of two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $8,280,000. In addition, the underwriters are entitled to a deferred underwriting discount of three and half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement. |
Warrants
Warrants | 3 Months Ended |
Mar. 31, 2023 | |
Warrant Liability Disclosure [Abstract] | |
WARRANTS | NOTE 7. WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Business Combination, it will use its best efforts to file with the SEC, and within 60 business days following the Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders. In addition, once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.10 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, provided that holders will be able to exercise their Public Warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to a formula set out in the warrant agreement; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders (the “30-day Reference Period”); and ● unless the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within the 30-day Reference Period, the Private Placement Warrants are also concurrently redeemed at the same price and terms as the outstanding Public Warrants (provided that the redemption may be on a cashless basis). If and when the Public Warrants become redeemable by the Company, it may exercise its redemption rights even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws; provided, that the Company will use its best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the Public Warrants were offered by the Company in the Initial Public Offering. The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger, or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants, except in the event of certain tender offers, as defined in the warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of the Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Board of Directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants will and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees (other than in the case the Public Warrants are redeemed for $0.10 as described above). If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. At March 31, 2023, there were 8,280,000 whole Public Warrants and 206,000 Private Placement Warrants outstanding with a fair value of $993,600 and $26,780, respectively. At December 31, 2022, there were 8,280,000 whole Public Warrants and 206,000 Private Placement Warrants outstanding with a fair value of $662,400 and $18,540, respectively. The Company accounts for the 8,280,000 Public Warrants and the 200,600 Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a derivative liability. The warrant agreement, dated February 4, 2021, by and between the Company and Continental, contains an Alternative Issuance provision that if less than 70% of the consideration receivable by the holders of the Class A common stock in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercise the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the warrant price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the common stock consists exclusively of cash, the amount of such cash per common stock, and (ii) in all other cases, the volume weighted average price of the common stock as reported during the ten-trading day period ending on the trading day prior to the effective date of the Business Combination. The Company believes that the adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815 – 40, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classifies each warrant as a liability at its fair value and the warrants have been allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to re-measurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the accompanying unaudited condensed statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification. |
Stockholders_ Equity
Stockholders’ Equity | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders’ Equity [Abstract] | |
STOCKHOLDERS’ EQUITY | NOTE 8. STOCKHOLDERS’ EQUITY The Company is authorized to issue 1,000,000 shares of $0.0001 par value preferred stock. At March 31, 2023 and December 31, 2022 , there were no preferred stock issued or outstanding. The Company is authorized to issue up to 200,000,000 shares of Class A, $0.0001 par value common stock. Holders of the Class A common stock are entitled to one vote for each share. there were 1,003,000 shares of Class A common stock issued or outstanding (excluding 1,097,741 Class A shares subject to possible redemption at , respectively). The Company is authorized to issue up to 20,000,000 shares of Class B, $0.0001 par value common stock. Holders of the Class B common stock are entitled to one vote for each share. On February 4, 2021, the Company effectuated a 1.2 for 1 dividend of the Class B common stock resulting in an aggregate of 10,350,000 shares of Class B common stock issued and outstanding. At , there were 10,350,000 shares of Class B common stock issued and outstanding. Holders of Class A common stock and Class B common stock vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law; provided that only holders of Class B common stock have the right to vote for the election of directors prior to the Company’s Business Combination. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations, and the like. In the case that additional shares of Class A common stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any Private Placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination. On December 16, 2022, the Company held a special meeting of its stockholders (the “2022 Special Meeting”). In connection with the 2022 Special Meeting, as set forth in the Company’s Current Report on Form 8-K filed with the SEC on December 22, 2022, the holders of 40,302,259 shares of the Class A common stock (the “Redeeming Stockholders”) properly exercised their right to redeem their shares for cash. On December 30, 2022, an initial redemption payment was made by Continental, as trustee of the Trust Account, to the Redeeming Stockholders at a rate of $10.10 per share and, on January 11, 2023, Continental made an additional redemption payment (the “Additional Payment”) to the Redeeming Stockholders at a rate of $0.02841302 per share, for a total redemption payment per share of $10.12841302. It was later determined that the Company did not withdraw all of the interest from the Trust Account that it was allowed to withdraw to cover income and franchise taxes and, therefore, the Additional Payment should have been $0.00157381 per share, for a total redemption payment of $10.10157381 per share. This meant that the Redeeming Stockholders were overpaid in the amount of $0.02683921 per share (the “Overpayment Amount”). The Redeeming Stockholders are in the process of being notified of this situation and are being instructed to return the Overpayment Amount to Continental. To date, the Company has recovered substantially all of the Overpayment Amount. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE MEASUREMENTS | NOTE 9. FAIR VALUE MEASUREMENTS “Fair value” is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, December 31, Assets: Cash and marketable securities held in Trust Account 1 $ 11,950,441 $ 12, 263,483 Liabilities: Public Warrants (1) 1 $ 993,600 $ 662,400 Private Placement Warrants (1) 2 26,780 18,540 (1) Measured at fair value on a recurring basis. The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the accompanying ondensed statements of operations. Initial Measurement The Company established the initial fair value for the warrants on February 10, 2021, the date of the Initial Public Offering, using a Monte Carlo simulation and Black-Scholes Merton formula for the Private Placement Warrants and the Public Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Public Share and one-fifth of one Public Warrant), and (ii) the sale of Private Placement Units, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to shares of Class A common stock subject to possible redemption based on their relative fair values at the initial measurement date. The Private Placement Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: February 10, Input 2021 Risk-free interest rate 74.00 % Expected term to consummate the Business Combination (years) 6.5 Expected Volatility 15 % Exercise Price $ 11.50 Stock price $ 9.80 The Company’s use of a Monte Carlo simulation and Black-Scholes Merton formula required the use of subjective assumptions: ● The risk-free interest rate assumption was based on the 6.5 year yield the yield on the U.S. Treasury notes as of the Valuation Date that matched the time period to consummate the Business Combination as of each Valuation Date. ● The expected term was simulated out daily over the expected remaining life of the Public Warrants. The specific remaining life was based on management’s estimated time to consummate the Business Combination as well as the five-year contractual period that begins once the transaction closes. ● The expected volatility assumption was based on the implied volatility from a set of comparable publicly-traded warrants as determined based on the size and proximity of other similar business combinations. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The fair value of the Units, which each consist of one Public Share and one-fifth of one Public Warrant, represents the closing price on the measurement date as observed from the ticker “TBCP”. Based on the applied volatility assumption and the expected term to a Business Combination noted above, the Company determined that the risk neutral probability of exceeding the $18.00 redemption value by the start of the exercise period for the warrants resulted in a nominal difference in value between the Public Warrants and Private Placement Warrants across the valuation dates utilized in the Monte Carlo simulation model. Therefore, the resulting valuations for the two classes of warrants were determined to be equal. On February 10, 2021, the Private Placement Warrants and Public Warrants were determined to be $1.57 per warrant for aggregate values of $12.6 million and $31.6 million, respectively. Subsequent Measurement The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of March 31, 2023 and December 31, 2022 is classified as Level 1 due to the use of an observable market quote in an active market under the ticker “TBCPW”. As the transfer of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is classified as Level 2, due to the use of observable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at the subsequent measurement date: Input March 31, Risk-free interest rate 3.60 % Expected term (years) 5 Expected term to consummate the Business Combination (years) 0.33 Expected Volatility 25.8 % Exercise Price $ 11.50 Stock price $ 10.02 As of March 31, 2023, the aggregate values of the Private Placement Warrants and Public Warrants were approximately $1.02 million. The following table presents the changes in the fair value of warrant liabilities: Private Placement Warrants Public Warrants Warrant Fair value as of January 1, 2023 $ 18,540 $ 662,400 $ 680,940 Change in valuation inputs or other assumptions (1) 8,240 331,200 339,440 Fair value as of March 31, 2023 $ 26,780 $ 993,600 $ 1,020,380 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations. The following table present the changes in fair value of the Level 3 Promissory Note- related party: Fair value as of January 1, 2023 $ 475,000 repayment of Promissory Note - Related Party (50,000 ) Change in fair value - Fair value as of March 31, 2023 $ 425,000 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three months ended March 31, 2023 for the Promissory Note. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | NOTE 10. INCOME TAXES As of March 31, 2023 and December 31, 2022, the Company’s net deferred tax assets are as follows: 2023 2022 Deferred tax asset: Organizational costs/Startup expenses $ 421,345 $ 386,136 Total deferred tax asset 421,345 386,136 Valuation allowance (421,345 ) (386,136 ) Deferred tax asset, net of allowance $ - $ - The Company will file taxes in the U.S. Federal jurisdiction. We have $0 in net operating loss carryovers at March 31, 2023. We are subject to taxation in the United States. As of December 31, 2022, we have no tax years under examination by the Internal Revenue Service. The U.S. federal tax returns for tax years 2023, 2022 and 2021 remain open to examination by the tax authorities. We have established a full valuation allowance for our deferred tax assets for the three months ended March 31, 2023 and for the year ended December 31, 2022, as it is more likely than not that these assets will not be realized in the foreseeable future. Our valuation allowance increased by $35,209 from 2022 to 2023. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Liquidity and Going Concern Consideration | Liquidity and Going Concern Consideration As of March 31, 2023, the Company had a working capital deficit of approximately $2,830,000, including approximately $318,000 in its operating bank account. The Company’s liquidity needs to date have been satisfied through (i) a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, (ii) an advance from an affiliate of the Sponsor of the payment of certain formation and operating costs on behalf of the Company and (iii) the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, as of March 31, 2023 and December 31, 2022, there were $425,000 and $450,000 amounts outstanding under the Promissory Note (see Note 5). In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), we have evaluated the Company’s liquidity and financial condition and determined that it is probable the Company will not be able to meet its obligations over the period of one year from the issuance date of the accompanying unaudited condensed financial statements. In addition, while the Company plans to seek additional funding or to consummate an initial Business Combination, there is no guarantee the Company will be able to borrow such funds from its Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors in order to meet its obligations through the earlier of the consummation of an initial Business Combination or one year from this filing. We have determined that the uncertainty surrounding the Company’s liquidity condition raises substantial doubt about its ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022, respectively. |
Income Taxes | Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. |
Shares Subject to Possible Redemption | Shares Subject to Possible Redemption The Company accounts for its shares subject to possible redemption in accordance with the guidance in ASC 480. Shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, shares are classified as stockholders’ equity. The Company’s shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2023 and December 31, 2022, shares subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the accompanying unaudited condensed balance sheets. |
Offering Costs | Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs are charged against the carrying value of Class A common stock or the statement of operations based on the relative value of the Class A common stock and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, offering costs in the aggregate of $23,191,740 were recognized, $463,835 of which was allocated to the warrants and immediately expensed included in formation costs and other operating expenses in the accompanying unaudited condensed statements of operations, and $22,727,905 was allocated to Class A common stock, reducing the carrying amount of such shares. |
Cash Held in Trust Account | Cash Held in Trust Account At March 31, 2023, the assets in the Trust Account were held in a demand deposit account and at December 31, 2022, the assets held in the Trust Account were invested in a money market fund. In February 2023, the assets held in the Trust Account were converted into cash. |
Net (Loss) Income Per Share of Common Stock | Net (Loss) Income Per Share of Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share” (“ASC 260”). We have two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of common stock outstanding during the period. The calculation of diluted loss per share does not consider the effect of the Public Warrants issued in connection with the Initial Public Offering and the sale of the Private Placement Warrants in the Private Placement, because the exercise of the warrants is contingent upon the occurrence of future events. A reconciliation of net (loss) income per share of common stock is as follows: For the Three Months Ended March 31, 2023 For the Three Months Ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net income per share Allocation of net income, as adjusted $ (86,143 ) $ (424,413 ) $ 1,982,103 $ 483,805 Less: Accretion allocated based on ownership percentage (9,835 ) (48,458 ) (29,668 ) (7,241 ) Plus: Accretion applicable to Class A redeemable shares 58,293 36,909 Income (loss) by class $ (37,685 ) $ (472,871 ) $ 1,989,344 $ 476,564 Denominator: Basic and diluted weighted average common shares outstanding 2,100,741 10,350,000 42,403,000 10,350,000 Basic and diluted net income (loss) per share $ (0.02 ) $ (0.05 ) $ 0.05 $ 0.05 |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the accompanying unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. |
Recently Issued Accounting Standards | Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements. |
Subsequent Events | Subsequent Events Management of the Company evaluates events that have occurred after the balance sheet date of March 31, 2023 through the date the financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of reconciliation of net (loss) income per share of common stock | For the Three Months Ended March 31, 2023 For the Three Months Ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net income per share Allocation of net income, as adjusted $ (86,143 ) $ (424,413 ) $ 1,982,103 $ 483,805 Less: Accretion allocated based on ownership percentage (9,835 ) (48,458 ) (29,668 ) (7,241 ) Plus: Accretion applicable to Class A redeemable shares 58,293 36,909 Income (loss) by class $ (37,685 ) $ (472,871 ) $ 1,989,344 $ 476,564 Denominator: Basic and diluted weighted average common shares outstanding 2,100,741 10,350,000 42,403,000 10,350,000 Basic and diluted net income (loss) per share $ (0.02 ) $ (0.05 ) $ 0.05 $ 0.05 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value liabilities | Description Level March 31, December 31, Assets: Cash and marketable securities held in Trust Account 1 $ 11,950,441 $ 12, 263,483 Liabilities: Public Warrants (1) 1 $ 993,600 $ 662,400 Private Placement Warrants (1) 2 26,780 18,540 (1) Measured at fair value on a recurring basis. |
Schedule of the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants | February 10, Input 2021 Risk-free interest rate 74.00 % Expected term to consummate the Business Combination (years) 6.5 Expected Volatility 15 % Exercise Price $ 11.50 Stock price $ 9.80 Input March 31, Risk-free interest rate 3.60 % Expected term (years) 5 Expected term to consummate the Business Combination (years) 0.33 Expected Volatility 25.8 % Exercise Price $ 11.50 Stock price $ 10.02 |
Schedule of the changes in the fair value of warrant liabilities | Private Placement Warrants Public Warrants Warrant Fair value as of January 1, 2023 $ 18,540 $ 662,400 $ 680,940 Change in valuation inputs or other assumptions (1) 8,240 331,200 339,440 Fair value as of March 31, 2023 $ 26,780 $ 993,600 $ 1,020,380 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations. |
Schedule of changes in fair value of the Level 3 Promissory Note- related party | Fair value as of January 1, 2023 $ 475,000 repayment of Promissory Note - Related Party (50,000 ) Change in fair value - Fair value as of March 31, 2023 $ 425,000 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of company’s net deferred tax assets | 2023 2022 Deferred tax asset: Organizational costs/Startup expenses $ 421,345 $ 386,136 Total deferred tax asset 421,345 386,136 Valuation allowance (421,345 ) (386,136 ) Deferred tax asset, net of allowance $ - $ - |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Feb. 10, 2021 | Dec. 16, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
Description of Organization and Business Operations (Details) [Line Items] | ||||
Exercise price per share (in Dollars per share) | $ 18 | |||
Transaction costs | $ 23,191,740 | |||
Underwriting fees | 8,280,000 | |||
Deferred underwriting fees | 14,490,000 | |||
Other costs | 421,740 | |||
Issuance of warrants | 463,835 | |||
Working capital | $ 1,263,117 | |||
Fair market value, percentage | 80% | |||
Net tangible assets | $ 5,000,001 | |||
Per share trust account | 10 | |||
Public shares | 100% | |||
Sponsor | 1,500,000 | |||
Borrowed amount | $ 475,000 | |||
IPO [Member] | ||||
Description of Organization and Business Operations (Details) [Line Items] | ||||
Number of units issued in transaction (in Shares) | 1,003,000 | |||
Gross proceeds from initial public offering | $ 414,000,000 | $ 10,030,000 | ||
Unit price (in Dollars per share) | $ 10 | $ 10 | ||
Class A Common stock [Member] | ||||
Description of Organization and Business Operations (Details) [Line Items] | ||||
Common stock, par value (in Dollars per share) | 0.0001 | $ 0.0001 | ||
Exercise price per share (in Dollars per share) | $ 11.5 | |||
Class A Common stock [Member] | IPO [Member] | ||||
Description of Organization and Business Operations (Details) [Line Items] | ||||
Number of units issued in transaction (in Shares) | 41,400,000 | |||
Gross proceeds from initial public offering | $ 414,000,000 | |||
Business Combination [Member] | ||||
Description of Organization and Business Operations (Details) [Line Items] | ||||
Outstanding voting percentage | 50% | |||
Business combination, description | If the Company is unable to complete a Business Combination by the end of the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board of Directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriters of the Initial Public Offering have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). | |||
Business combination , descriptions | The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. | |||
Business Combination [Member] | IPO [Member] | ||||
Description of Organization and Business Operations (Details) [Line Items] | ||||
Business combination period, description | If the Company has not completed a Business Combination by the end of the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then outstanding Public Shares, which redemption will completely extinguish the rights of the Public Stockholders as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. In the event of a liquidation, the Public Stockholders will be entitled to receive a full pro rata interest in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the Trust Fund not previously released to the Company and less up to $100,000 of interest to pay dissolution expenses). |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Summary of Significant Accounting Policies (Details) [Line Items] | ||
Working capital deficit | $ 2,830,000 | |
Operating bank account | 318,000 | |
Expenses | 25,000 | |
Amounts outstanding | 425,000 | $ 450,000 |
Warrants | 463,835 | |
Carrying amount | 22,727,905 | |
Federal depository insurance corporation coverage | 250,000 | |
IPO [Member] | ||
Summary of Significant Accounting Policies (Details) [Line Items] | ||
Offering costs | $ 23,191,740 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of net (loss) income per share of common stock - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A [Member] | ||
Basic and diluted net income per share Numerator: | ||
Allocation of net income, as adjusted | $ (86,143) | $ 1,982,103 |
Less: Accretion allocated based on ownership percentage | (9,835) | (29,668) |
Plus: Accretion applicable to Class A redeemable shares | 58,293 | 36,909 |
Income (loss) by class | $ (37,685) | $ 1,989,344 |
Denominator: | ||
Basic and diluted weighted average common shares outstanding (in Shares) | 2,100,741 | 42,403,000 |
Basic and diluted net income (loss) per share (in Dollars per share) | $ (0.02) | $ 0.05 |
Class B [Member] | ||
Basic and diluted net income per share Numerator: | ||
Allocation of net income, as adjusted | $ (424,413) | $ 483,805 |
Less: Accretion allocated based on ownership percentage | (48,458) | (7,241) |
Plus: Accretion applicable to Class A redeemable shares | ||
Income (loss) by class | $ (472,871) | $ 476,564 |
Denominator: | ||
Basic and diluted weighted average common shares outstanding (in Shares) | 10,350,000 | 10,350,000 |
Basic and diluted net income (loss) per share (in Dollars per share) | $ (0.05) | $ 0.05 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of net (loss) income per share of common stock (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A [Member] | ||
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of net (loss) income per share of common stock (Parentheticals) [Line Items] | ||
Diluted weighted average common shares outstanding | 2,100,741 | 42,403,000 |
Diluted net income (loss) per share | $ (0.02) | $ 0.05 |
Class B [Member] | ||
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of net (loss) income per share of common stock (Parentheticals) [Line Items] | ||
Diluted weighted average common shares outstanding | 10,350,000 | 10,350,000 |
Diluted net income (loss) per share | $ (0.05) | $ 0.05 |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | 3 Months Ended | |
Feb. 10, 2021 | Mar. 31, 2023 | |
Initial Public Offering (Details) [Line Items] | ||
Description of warrants | Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 7). | |
Initial Public Offering [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Number of units issued in transaction (in Dollars) | $ 41,400,000 | |
Unit price | $ 10 | |
Over-Allotment Option [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Unit price | $ 10 | |
Purchase share (in Shares) | 5,400,000 |
Private Placement (Details)
Private Placement (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) $ / shares shares | |
Private Placement (Details) [Line Items] | |
Exercise price | $ / shares | $ 10 |
Private Placement [Member] | |
Private Placement (Details) [Line Items] | |
Aggregate purchase price | shares | 1,003,000 |
Aggregate of private placement | $ | $ 10,030,000 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
Feb. 10, 2021 | Mar. 25, 2022 | Feb. 28, 2021 | Aug. 26, 2020 | Mar. 31, 2023 | Dec. 31, 2022 | |
Related Party Transactions (Details) [Line Items] | ||||||
Dividend shares (in Dollars per share) | $ 0.2 | |||||
Issued and outstanding shares rate | 20% | |||||
Business combination converted | $ 1,500,000 | |||||
Outstanding amount | 425,000 | $ 475,000 | ||||
Fair Value, Option, Changes in Fair Value, Gain (Loss) | 425,000 | 475,000 | ||||
Payment for office space | $ 10,000 | |||||
Incurred amount | 30,000 | |||||
Over-Allotment Option [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Purchase share (in Shares) | 5,400,000 | |||||
Unit price (in Dollars per share) | $ 10 | |||||
IPO [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Unit price (in Dollars per share) | $ 10 | |||||
Cover expenses | $ 1,500,000 | |||||
Advisory Agreement [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Incurred amount | $ 60,000 | $ 60,000 | ||||
Class B Common Stock [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Shares subject to forfeiture (in Shares) | 1,350,000 | |||||
Class B Common Stock [Member] | Founders Shares [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Aggregate of founder shares (in Shares) | 8,625,000 | |||||
Aggregate price of founder shares | $ 25,000 | |||||
Chief Executive Officer [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Advisor fees | $ 20,000 | |||||
Business Combination [Member] | Founders Shares [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Business combination, description | The Sponsor has agreed not to transfer, assign, or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities, or other property. Notwithstanding the foregoing, if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. | |||||
Business Combination [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Business combination share price (in Dollars per share) | $ 10 | |||||
Sponsor [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Aggregate of founder shares (in Shares) | 10,350,000 | |||||
Chief Executive Officer [Member] | IPO [Member] | ||||||
Related Party Transactions (Details) [Line Items] | ||||||
Purchased shares (in Shares) | 100,000 | |||||
Share price (in Dollars per share) | $ 10 | |||||
Aggregate purchase price | $ 1,000,000 |
Commitments (Details)
Commitments (Details) - USD ($) | 3 Months Ended | |
Feb. 10, 2021 | Mar. 31, 2023 | |
Commitments (Details) [Line Items] | ||
Underwriting discount percent | 3.50% | |
Gross proceeds | $ 14,490,000 | |
Over-Allotment Option [Member] | ||
Commitments (Details) [Line Items] | ||
Underwriter additional units | 5,400,000 | |
IPO [Member] | ||
Commitments (Details) [Line Items] | ||
Underwriting discount percent | 2% | |
Gross proceeds | $ 8,280,000 |
Warrants (Details)
Warrants (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Warrants (Details) [Line Items] | ||
Public warrants expire | 5 years | |
Public warrant, description | In addition, once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.10 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, provided that holders will be able to exercise their Public Warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to a formula set out in the warrant agreement; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders (the “30-day Reference Period”); and ● unless the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within the 30-day Reference Period, the Private Placement Warrants are also concurrently redeemed at the same price and terms as the outstanding Public Warrants (provided that the redemption may be on a cashless basis). | |
Warrant price (in Dollars per share) | $ 18 | |
Fair value (in Dollars) | $ 26,780 | |
Public warrants | 8,280,000 | |
Private placement warrants | 206,000 | |
Consideration receivable percentage | 70% | |
Public Warrants [Member] | ||
Warrants (Details) [Line Items] | ||
Public warrant, description | Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders. | |
Warrant price (in Dollars per share) | $ 0.1 | |
Warrants | 8,280,000 | |
Public warrants | 8,280,000 | |
Fair value (in Dollars) | $ 662,400 | |
Private Placement Warrants [Member] | ||
Warrants (Details) [Line Items] | ||
Warrants | 206,000 | |
Fair value (in Dollars) | $ 993,600 | |
Private placement warrants | 200,600 | |
Fair value (in Dollars) | $ 18,540 | |
Business Combination [Member] | ||
Warrants (Details) [Line Items] | ||
Business combination, description | In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Board of Directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price. |
Stockholders_ Equity (Details)
Stockholders’ Equity (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |||
Jan. 11, 2023 | Feb. 04, 2021 | Dec. 30, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
Stockholders’ Equity (Details) [Line Items] | |||||
Preferred shares authorized | 1,000,000 | 1,000,000 | |||
Preferred shares, par value | $ 0.0001 | $ 0.0001 | |||
Shares subject to possible redemption | $ 1,097,741 | $ 41,400,000 | |||
Additional warrants, description | In the case that additional shares of Class A common stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any Private Placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company). | ||||
Holders shares | 40,302,259 | ||||
Per share | $ 0.02841302 | $ 10.1 | $ 0.02683921 | ||
Redemption share | $ 10.12841302 | 10.10157381 | |||
Additional payment per share | $ 0.00157381 | ||||
Class A Common Stock [Member] | |||||
Stockholders’ Equity (Details) [Line Items] | |||||
Common stock, shares authorized | 200,000,000 | 200,000,000 | |||
Common stock, par value | $ 0.0001 | $ 0.0001 | |||
Common stock issued | 1,003,000 | 0 | |||
Common stock outstanding | 1,003,000 | 0 | |||
Class B Common Stock [Member] | |||||
Stockholders’ Equity (Details) [Line Items] | |||||
Common stock, shares authorized | 20,000,000 | 20,000,000 | |||
Common stock, par value | $ 0.0001 | $ 0.0001 | |||
Common stock issued | 10,350,000 | 10,350,000 | |||
Common stock outstanding | 10,350,000 | 10,350,000 | |||
Stock split dividend, description | the Company effectuated a 1.2 for 1 dividend of the Class B common stock resulting in an aggregate of 10,350,000 shares of Class B common stock issued and outstanding. |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Feb. 10, 2021 | Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | ||
Fair value yield term | 6 years 6 months | |
Warrants per share | $ 18 | |
Warrants, description | the Private Placement Warrants and Public Warrants were determined to be $1.57 per warrant for aggregate values of $12.6 million and $31.6 million, respectively. | |
Aggregate of public warrants | $ 1,020 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of fair value liabilities - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | ||
Level 1 [Member] | |||
Assets: | |||
Cash and marketable securities held in Trust Account | [1] | $ 11,950,441 | $ 12,263,483 |
Liabilities: | |||
Public Warrants | [1] | 993,600 | 662,400 |
Level 2 [Member] | |||
Liabilities: | |||
Private Placement Warrants | [1] | $ 26,780 | $ 18,540 |
[1] Measured at fair value on a recurring basis. |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants - $ / shares | 3 Months Ended | |
Feb. 10, 2021 | Mar. 31, 2023 | |
Schedule Of The Monte Carlo Simulation Model For The Private Placement Warrants And Public Warrants Abstract | ||
Risk-free interest rate | 74% | 3.60% |
Expected term (years) | 5 years | |
Expected term to consummate the Business Combination (years) | 6 years 6 months | 3 months 29 days |
Expected Volatility | 15% | 25.80% |
Exercise Price | $ 11.5 | $ 11.5 |
Stock price | $ 9.8 | $ 10.02 |
Fair Value Measurements (Deta_4
Fair Value Measurements (Details) - Schedule of the changes in the fair value of warrant liabilities | 3 Months Ended | |
Mar. 31, 2023 USD ($) | ||
Private Placement [Member] | ||
Fair Value Measurements (Details) - Schedule of the changes in the fair value of warrant liabilities [Line Items] | ||
Fair value as of beginning balance | $ 18,540 | |
Change in valuation inputs or other assumptions | 8,240 | [1] |
Fair value as of ending balance | 26,780 | |
Public [Member] | ||
Fair Value Measurements (Details) - Schedule of the changes in the fair value of warrant liabilities [Line Items] | ||
Fair value as of beginning balance | 662,400 | |
Change in valuation inputs or other assumptions | 331,200 | [1] |
Fair value as of ending balance | 993,600 | |
Warrant Liabilities [Member] | ||
Fair Value Measurements (Details) - Schedule of the changes in the fair value of warrant liabilities [Line Items] | ||
Fair value as of beginning balance | 680,940 | |
Change in valuation inputs or other assumptions | 339,440 | [1] |
Fair value as of ending balance | $ 1,020,380 | |
[1] Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations. |
Fair Value Measurements (Deta_5
Fair Value Measurements (Details) - Schedule of changes in fair value of the Level 3 Promissory Note- related party | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Schedule of Changes in Fair Value of the Level3 Promissory Note Related Party [Abstract] | |
Fair value as of beginning balance | $ 475,000 |
repayment of Promissory Note - Related Party | (50,000) |
Change in fair value | |
Fair value as of ending balance | $ 425,000 |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Income Tax Disclosure [Abstract] | |
Net operating loss carryovers | $ 0 |
Valuation allowance | $ 35,209 |
Income Taxes (Details) - Schedu
Income Taxes (Details) - Schedule of company’s net deferred tax assets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Schedule of Company’s Net Deferred Tax Assets [Abstract] | ||
Organizational costs/Startup expenses | $ 421,345 | $ 386,136 |
Total deferred tax asset | 421,345 | 386,136 |
Valuation allowance | (421,345) | (386,136) |
Deferred tax asset, net of allowance |